Picture of Vericel logo

VCEL — Vericel News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Vericel Corp expected to post a loss of 15 cents a share - Earnings Preview

* Vericel Corp  VCEL.OQ   VCEL.O  is expected to show a rise
in
quarterly revenue when it reports  results on August 2. 
    * The Cambridge Massachusetts-based  company is expected to
report
 a 13.7% increase in revenue to $42.134 million from $37.05
million a year ago, according to the mean estimate from 5
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Vericel Corp is for
a
loss of 15 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Vericel
Corp is
$42​, above​ its last closing price of $37.78. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -0.15       -0.15      -0.16     Missed  -4.4
 Dec. 31 2023  0.04        0.04       0.12      Beat    239
 Sep. 30 2022  -0.10       -0.10      -0.14     Missed  -37.3​
 Jun. 30 2022  -0.12       -0.12      -0.19     Missed  -55.5
 ​​Mar.        -0.10       -0.12      -0.15     Missed  -28.6
 31 2022                                                
 Dec. 31 2021  0.15        0.14       0.09      Missed  -37.2​
 Sep. 30 2021  -0.03       -0.03      -0.11     Missed  -305.3
 Jun. 30 2021  -0.09       -0.08      -0.08     Met     4.5
 This summary was machine generated July 31 at 18:32 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Vericel

See all news